Skip to main content
Date :

๐Ÿ“ฃ Join HBA Cambridge and Deloitte for ๐๐ข๐จ๐ง๐ž๐ž๐ซ๐ข๐ง๐  ๐๐ซ๐ž๐ฏ๐ž๐ง๐ญ๐ข๐จ๐ง ๐Ÿ๐จ๐ซ ๐š ๐‡๐ž๐š๐ฅ๐ญ๐ก๐ข๐ž๐ซ ๐…๐ฎ๐ญ๐ฎ๐ซ๐ž on 30 September.

This event will explore how a prevention-first approach can improve health outcomes, reduce health inequalities, strengthen healthcare sustainability, and keep the patient voice at the heart of innovation.

Hear from leaders across healthcare, life sciences, public health, and patient advocacy, with the discussion moderated by Elizabeth Hampson, UK Life Sciences and Health Innovation Partner at Deloitte.

๐Ÿ•  5:45 PM โ€“ 8:30 PM BST

  • Dr. Carina Kern, LinkGevity
  • Dr Juliet Usher-Smith, University of Cambridge
  • Tim Bennett, Illumina
  • Professor Simon Kenny, NHS England
  • Rachael Griffin, Jazz Pharmaceuticals & HBA Cambridge
Venue and Location Information:
๐Ÿ“ย Deloitte Offices, 1 Station Square, Cambridge, CB1 2GA
Event Registration Link:
https://my.hbanet.org/EVENTS-PROGRAMS/AddEdit/EventDetails/MeetingID/6066bc12-2โ€ฆ